Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Onkologie 2011; 34: 254-258.
- Keyword
-
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2013
- Contributor
- URN
-
urn:nbn:de:bvb:29-opus-42950
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hullard-Pulstinger, Annette
- Holler, Ernst
- Hahn, Joachim
- Andreesen, Reinhard
- Krause, Stefan W.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2013
Other Objects (12)
Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry
Multiple Intravitreal Liposomal Amphotericin B for a Case of Candida glabrata Endophthalmitis
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients
Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report
Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry
Multiple Intravitreal Liposomal Amphotericin B for a Case of Candida glabrata Endophthalmitis
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients
Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report
Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry
Multiple Intravitreal Liposomal Amphotericin B for a Case of Candida glabrata Endophthalmitis
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
Feasibility, acceptance and safety of treating visceral leishmaniasis patients with liposomal amphotericin B in rural Bangladesh
Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients